|
Market Closed -
Australian S.E.
03:03:09 30/10/26 pm AEDT
|
5-day change | 1st Jan Change | ||
| 0.2400 AUD | +2.13% |
|
-.--% | -28.36% |
| 25/08 | Compumedics Limited Reports Earnings Results for the Full Year Ended June 30, 2026 | CI |
| 25/08 | Compumedics Fiscal 2026 EBITDA, Revenue Up | MT |
Company Valuation: Compumedics Limited
Data adjusted to current consolidation scope
| Fiscal Period: June | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 59.35 | 48.97 | 50.94 | 47.94 | - | - |
| Change | - | -17.49% | 4.02% | -5.88% | - | - |
| Enterprise Value (EV) | 59.35 | 48.97 | 50.94 | 47.94 | 47.94 | 47.94 |
| Change | - | -17.49% | 4.02% | -5.88% | 0% | 0% |
| P/E | -335x | -36.4x | 255x | 11.4x | 7.5x | 5.45x |
| PBR | - | - | - | - | - | - |
| PEG | - | -0x | -2x | 0x | 0.1x | 0.1x |
| Capitalization / Revenue | - | 0.96x | 0.85x | 0.63x | 0.53x | 0.43x |
| EV / Revenue | - | 0x | 0x | 0.63x | 0.53x | 0.43x |
| EV / EBITDA | - | 0x | 0x | 5.33x | 3.93x | 3.05x |
| EV / EBIT | - | 0x | 0x | 7.38x | 4.99x | 3.69x |
| EV / FCF | - | -0x | 0x | 15x | 8.56x | 6.75x |
| FCF Yield | - | -13.7% | 5.3% | 6.67% | 11.7% | 14.8% |
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | -0.001 | -0.007 | 0.001 | 0.021 | 0.032 | 0.044 |
| Distribution rate | - | - | - | - | - | - |
| Net sales 1 | - | 50.96 | 60.25 | 75.6 | 91 | 112 |
| EBITDA 1 | - | 2.938 | 3.985 | 9 | 12.2 | 15.7 |
| EBIT 1 | - | 0.692 | 1.787 | 6.5 | 9.6 | 13 |
| Net income 1 | -0.499 | -1.272 | 0.214 | 6 | 9.2 | 12.5 |
| Net Debt | - | - | - | - | - | - |
| Reference price 2 | 0.3350 | 0.2550 | 0.2550 | 0.2400 | 0.2400 | 0.2400 |
| Nbr of stocks (in thousands) | 177,163 | 192,039 | 199,762 | 199,762 | - | - |
| Announcement Date | 30/8/24 | 26/8/25 | 24/8/26 | - | - | - |
1AUD in Million2AUD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 11.43x | - | - | - | 33.73M | |
| 35.69x | 6.08x | 23.25x | 0.27% | 258B | |
| 36.92x | 7x | 21.93x | 0.62% | 163B | |
| 49.76x | 12.05x | 25.86x | -.--% | 150B | |
| 17x | 3.45x | 11.22x | -.--% | 60.84B | |
| 21x | 2.51x | 12.66x | 2.4% | 53.31B | |
| 36.47x | 7.31x | 23.11x | -.--% | 53.03B | |
| 47.92x | 11.82x | 26.05x | -.--% | 50.67B | |
| 34.07x | 6.75x | 22.92x | 0.59% | 49.3B | |
| 81x | 7.7x | 23.37x | -.--% | 45.46B | |
| Average | 37.13x | 7.19x | 21.15x | 0.43% | 88.4B | |
| Weighted average by Cap. | 39.12x | 7.39x | 22.12x | 0.37% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- CMP Stock
- Valuation Compumedics Limited
Select your edition
All financial news and data tailored to specific country editions
